Yelda Jozaghi
University of Texas MD Anderson Cancer Center
9 Papers
60 Citations
Yelda Jozaghi is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 5, co-authored 6 publications.
Chat about Author
Papers
Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
Yelda Jozaghi,Mark Zafereo,Michelle D. Williams,Maria Gule-Monroe,Jennifer Wang,Elizabeth G. Grubbs,Ara A. Vaporciyan,Mimi I. Hu,Naifa L. Busaidy,Ramona Dadu,Steven G. Waguespack,Vivek Subbiah,Maria E. Cabanillas +12 more
TL;DR: The advent of highly selective, potent RET inhibitors is broadening the treatment options for patients with RET‐mutations, and selpercatinib was recently approved for advanced MTC.
57
Overview of COVID-19 testing and implications for otolaryngologists.
Daniel B. Vinh,Xiao Zhao,Kimberley L. Kiong,Theresa Guo,Yelda Jozaghi,Chris Yao,James M. Kelley,Ehab Y. Hanna +7 more
TL;DR: Testing for SARS‐CoV‐2 is important for decision making prior to surgery in otolaryngology and an understanding of current and developing testing methods is needed for interpreting test results.
Endocrine surgery in the Coronavirus disease 2019 pandemic: Surgical Triage Guidelines.
Yelda Jozaghi,Mark Zafereo,Nancy D. Perrier,Jennifer Wang,Elizabeth G. Grubbs,Neil D. Gross,Sarah B. Fisher,Erich M. Sturgis,Ryan P. Goepfert,Stephen Y. Lai,Conor Best,Naifa L. Busaidy,Maria E. Cabanillas,Ramona Dadu,Robert F. Gagel,Mouhammed Amir Habra,Mimi I. Hu,Camilo Jimenez,Steven I. Sherman,Sonali Thosani,Jeena Varghese,Steven G. Waguespack,Steven P. Weitzman,Anita K. Ying,Paul H. Graham +24 more
TL;DR: In the face of the COVID‐19 pandemic, cancer care has had to adapt rapidly given the Centers for Disease Control and Prevention and the American College of Surgeons issuing recommendations to postpone nonurgent surgeries.
34
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors
TL;DR: Functional and QOL outcomes among patients treated predominantly for sinonasal and nasopharyngeal malignancies, including skull base tumors, are reviewed.
15
The combined profunda artery perforator‐gracilis flap for immediate facial reanimation and resurfacing of the radical parotidectomy defect
Christopher Yao,Yelda Jozaghi,S. Danker,Reem Karami,Malke Asaad,Stephen Y. Lai,Ehab Y. Hanna,Bita Esmaeli,Paul W. Gidley,Edward F. Chang +9 more
TL;DR: In this paper , the feasibility and outcomes of a combined free gracilis and profunda artery perforator (PAP) flap from a single donor site can reconstruct these extensive defects and potentially restore dynamic facial reanimation even in the setting of adjuvant radiation.
5